Effects of zonisamide on dementia with Lewy bodies (DLB): A post-hoc analysis of phase 2 study for parkinsonism in DLB patients
Objective: To clarify the effects of zonisamide (ZNS) on the core symptoms of dementia with Lewy bodies (DLB), we performed a post-hoc analysis using data…Relationship of MDS-UPDRS non-motor symptoms to cognitive functioning in patients with Parkinson’s disease
Objective: To evaluate the relationship among individual items from the MDS-UPDRS Part I and measures of cognitive functioning in patients with PD. Background: Non-motor symptoms…Speech prosody impairment predicts cognitive decline in Parkinson’s disease
Objective: We assessed whether baseline speech prosodic parameters, alone or in combination with other predominantly non-dopaminergic symptoms may predict global cognitive decline as measured by…Analysis of factors associated with cognitive and functional performance in Parkinsonian with normal mini-mental state examination
Objective: To evaluate the correlation between cognitive and functional performance of Parkinsonian with normal Mini-Mental State Examination (MMSE), and demographic variables, motor impairment, neuropsychiatric disorders…Scores and dimensions to assess cognitive impairment in Parkinson’s disease
Objective: To provide inside into the nature of cognitive deterioration in Parkinson's disease dementia (PDD) and to define a score discriminating PDD patients from non-demented…Use of dementia rating scale-II (DRS-II) total score in PD deep brain stimulation (DBS) candidacy determination
Objective: To evaluate utility of the DRS-II Total Score for stratifying cognitive status in PD patients without frank cognitive impairment. Background: The DRS-II, a screening…Affective theory of mind in Parkinson’s disease
Objective: The aim of this study is to assess the hypothesis that patients with PD may show difficulties in tasks related to affective theory of…Magnetic resonance characteristic of Parkinson’s disease based on the presence of cognitive impairment
Objective: To study the performance of MRI in patients with Parkinson's disease, depending on the stage of the disease. Background: Steadily progressive chronic neurodegenerative disease…Frequency and characteristics of diplopia in non-demented patients with Parkinson’s disease
Objective: To assess the frequency of diplopia and its relation to motor and non-motor symptoms in a cross sectional sample of non-demented patients with idiopathic…Chronic cerebral hypoperfusion accelerates cognitive dysfunction and microvascular impairment in the MPTP mouse model of Parkinson’s disease
Objective: To evaluate cerebral hypoperfusion on cognitive dysfunction and related microvascular impairment in the MPTP mouse model. Background: Vascular pathology and Parkinson's disease (PD) pathology…
- « Previous Page
- 1
- …
- 116
- 117
- 118
- 119
- 120
- …
- 128
- Next Page »